Shares of companies testing Ebola vaccines rise

SHARE Shares of companies testing Ebola vaccines rise

NEW YORK (AP) — Shares of companies that are studying potential vaccines for Ebola are climbing in aftermarket trading after federal officials announced that the first case of the disease has been diagnosed in the U.S.

The Centers for Disease Control says a patient being treated at a hospital in Dallas tested positive for the disease.

Ebola is believed to have sickened more than 6,500 people in West Africa, and more than 3,000 people have died. Symptoms can start as much as 21 days after exposure, and the disease isn’t contagious until symptoms begin. It takes close contact with bodily fluids to spread.

The World Health Organization has worked to speed up the use of some experimental vaccines and companies are ramping up testing.

The Latest
Investigators have gotten different versions of what happened Friday evening when Cecilia Thomas was shot in the head in the 7700 block of South Shore Drive, according to Chicago police Supt. David Brown.
There were 243 passengers and 12 crew members on board the train. Officials said there were early reports of injuries.
“I have to give a shout-out to the police. They did an amazing job. There were plenty of police resources,” Ald. Tom Tunney (44th) said. “Given the volume of people that were here, they did a great job…I couldn’t have asked for anything more.”
The owners were bombarded with calls once news of the Bridgeport institution’s closure spread. “We know we are always busy, but the way they think about the food, and about everything is amazing,” co-owner Josie Rodriguez said.
“I know everyone wants COVID to be over,” said Chicago Department of Public Health Commissioner Dr. Allison Arwady. “Unfortunately, we continue to see the COVID virus itself mutate quickly, with new, more contagious subvariants emerging every few weeks.”